Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctiontransmembrane-ephrin receptor activity

EPHA10 EPHA3

3.65e-0415382GO:0005005
GeneOntologyMolecularFunctionkinase activity

PMS2P1 PFKFB3 MAP3K6 EPHA10 PKN3 EPHA3 MARK4

5.23e-04764387GO:0016301
GeneOntologyMolecularFunctionephrin receptor activity

EPHA10 EPHA3

5.91e-0419382GO:0005003
DomainSAM/pointed

SHANK2 MAP3K6 CASKIN1 EPHA10 EPHA3

2.47e-06117355IPR013761
DomainSAM

SHANK2 CASKIN1 EPHA10 EPHA3

2.15e-0588354SM00454
DomainSAM_DOMAIN

SHANK2 CASKIN1 EPHA10 EPHA3

2.91e-0595354PS50105
DomainSAM

SHANK2 CASKIN1 EPHA10 EPHA3

3.16e-0597354IPR001660
Domain-

SHANK2 CASKIN1 EPHA10 EPHA3

4.48e-051063541.10.150.50
DomainSAM_1

SHANK2 CASKIN1 EPHA10

2.78e-0468353PF00536
DomainRECEPTOR_TYR_KIN_V_2

EPHA10 EPHA3

3.06e-0414352PS00791
DomainRECEPTOR_TYR_KIN_V_1

EPHA10 EPHA3

3.06e-0414352PS00790
DomainEphA2_TM

EPHA10 EPHA3

3.06e-0414352PF14575
DomainTyr_kinase_ephrin_rcpt

EPHA10 EPHA3

3.06e-0414352IPR016257
DomainEph_TM

EPHA10 EPHA3

3.06e-0414352IPR027936
DomainEphrin_rcpt_lig-bd_dom

EPHA10 EPHA3

3.06e-0414352IPR001090
DomainTyr_kinase_rcpt_V_CS

EPHA10 EPHA3

3.06e-0414352IPR001426
DomainEPH_LBD

EPHA10 EPHA3

3.06e-0414352PS51550
DomainEPH_lbd

EPHA10 EPHA3

3.06e-0414352SM00615
DomainEphrin_lbd

EPHA10 EPHA3

3.06e-0414352PF01404
DomainEphrin_rec_like

EPHA10 EPHA3

9.96e-0425352SM01411
DomainTyr-kin_ephrin_A/B_rcpt-like

EPHA10 EPHA3

9.96e-0425352IPR011641
DomainPROTEIN_KINASE_ATP

MAP3K6 EPHA10 PKN3 EPHA3 MARK4

1.55e-03459355PS00107
DomainProt_kinase_dom

MAP3K6 EPHA10 PKN3 EPHA3 MARK4

2.05e-03489355IPR000719
DomainPROTEIN_KINASE_DOM

MAP3K6 EPHA10 PKN3 EPHA3 MARK4

2.12e-03493355PS50011
DomainKinase-like_dom

MAP3K6 EPHA10 PKN3 EPHA3 MARK4

3.19e-03542355IPR011009
DomainProtein_kinase_ATP_BS

MAP3K6 PKN3 EPHA3 MARK4

5.32e-03379354IPR017441
DomainSH3

SHANK2 SRGAP3 CASKIN1

7.60e-03216353PS50002
DomainSH3

SHANK2 SRGAP3 CASKIN1

7.60e-03216353SM00326
DomainSH3_domain

SHANK2 SRGAP3 CASKIN1

7.99e-03220353IPR001452
Domain-

EPHA10 EPHA3

8.25e-03733522.60.120.260
DomainSH3_2

SHANK2 CASKIN1

1.13e-0286352IPR011511
DomainSH3_2

SHANK2 CASKIN1

1.13e-0286352PF07653
DomainTyrKc

EPHA10 EPHA3

1.18e-0288352SM00219
DomainTyr_kinase_cat_dom

EPHA10 EPHA3

1.18e-0288352IPR020635
DomainGalactose-bd-like

EPHA10 EPHA3

1.34e-0294352IPR008979
DomainPROTEIN_KINASE_TYR

EPHA10 EPHA3

1.42e-0297352PS00109
Pubmed

A dual-activity topoisomerase complex regulates mRNA translation and turnover.

MICALL1 KDM3B PRR12 SCAF1 DLX2 TBKBP1 SHANK2 FBXO46 CASKIN1 ZNF408 PKN3 MARK4

1.77e-091105391235748872
Pubmed

Dendritic spine morphology and memory formation depend on postsynaptic Caskin proteins.

SHANK2 CASKIN1

3.67e-06339231727973
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

MICALL1 KDM3B SRRM2 MAP3K6 ARHGEF1 FAM110B MARK4 KIF2C

4.26e-0686139836931259
Pubmed

Sequential assembly of centromeric proteins in male mouse meiosis.

INCENP KIF2C

3.42e-05839219283064
Pubmed

Embryonic expression of EphA receptor genes in mice supports their candidacy for involvement in cleft lip and palate.

EPHA10 EPHA3

5.48e-051039225073978
Pubmed

EphA receptors inhibit anti-CD3-induced apoptosis in thymocytes.

EPHA10 EPHA3

5.48e-051039216547242
Pubmed

Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry.

PKN3 EPHA3 MARK4

9.36e-057839317192257
Pubmed

A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.

SHANK2 MRGPRG-AS1 INCENP SRRM2 EPHA3

1.03e-0442039528065597
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

SCAF1 HOXC13 KMT2E SRRM2

1.34e-0423339437704626
Pubmed

Development of the prethalamus is crucial for thalamocortical projection formation and is regulated by Olig2.

DLX2 EPHA3

1.85e-041839224803655
Pubmed

Sp9 Regulates Medial Ganglionic Eminence-Derived Cortical Interneuron Development.

DLX2 EPHA3

3.33e-042439229878134
Pubmed

Pax9 is required for filiform papilla development and suppresses skin-specific differentiation of the mammalian tongue epithelium.

HOXC13 LCE3D

3.91e-042639215454262
Pubmed

A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene.

KDM3B MRGPRG-AS1 WWC1 KIF2C

5.10e-0433139419490893
Pubmed

HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.

INCENP KIF2C

5.95e-043239227114546
Pubmed

Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.

SHANK2 SRRM2 SRGAP3 CASKIN1

6.08e-0434739417114649
Pubmed

MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.

SCAF1 DLX2 SRRM2 EPHA3

6.83e-0435839432460013
Pubmed

Oncogenic ZMYND11-MBTD1 fusion protein anchors the NuA4/TIP60 histone acetyltransferase complex to the coding region of active genes.

KDM3B SRRM2

1.03e-034239235705031
InteractionTOP3B interactions

MICALL1 KDM3B PRR12 SCAF1 DLX2 TBKBP1 SHANK2 FBXO46 CASKIN1 ZNF408 PKN3 MARK4

9.85e-0614703812int:TOP3B
Cytoband5q34

WWC1 FOXI1

3.43e-04323925q34
CytobandEnsembl 112 genes in cytogenetic band chr19q13

PRR12 SCAF1 MBOAT7 FBXO46 ARHGEF1 MARK4

4.74e-041192396chr19q13
CytobandEnsembl 112 genes in cytogenetic band chr7q22

PMS2P1 KMT2E ATXN7L1

8.62e-04219393chr7q22
Cytoband9q34.11

USP20 PKN3

9.43e-04533929q34.11
CytobandEnsembl 112 genes in cytogenetic band chr1p34

ZMYM6 EPHA10 KIF2C

2.00e-03294393chr1p34
Cytoband19q13.3

FBXO46 MARK4

2.24e-038239219q13.3
Cytoband7q22.1

PMS2P1 KMT2E

4.19e-031133927q22.1
GeneFamilySterile alpha motif domain containing

SHANK2 CASKIN1 EPHA10 EPHA3

7.22e-0688264760
GeneFamilyFibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors

EPHA10 EPHA3

1.79e-04142621095
Drugretinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A_EA

DLX2 PFKFB3 HOXC13 MAP3K6 FOXI1

9.41e-06167395966_UP
DrugTranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; HL60; HG-U133A

DLX2 SLC15A3 FBXO46 USP20 WWC1

1.80e-051913951417_UP
DrugNorethindrone [68-22-4]; Up 200; 13.4uM; HL60; HT_HG-U133A

MICALL1 DLX2 SHANK2 SLC15A3 INCENP

1.85e-051923952383_UP
DrugTiapride hydrochloride [51012-33-0]; Down 200; 11uM; PC3; HT_HG-U133A

DLX2 SHANK2 MAP3K6 ARHGEF1 ZNF408

1.99e-051953957362_DN
DrugAzaperone [1649-18-9]; Down 200; 12.2uM; PC3; HT_HG-U133A

DLX2 SRRM2 MAP3K6 USP20 MARK4

2.04e-051963955877_DN
DrugEthamsylate [2624-44-4]; Down 200; 15.2uM; PC3; HT_HG-U133A

DLX2 SHANK2 MBOAT7 ZNF408 MARK4

2.14e-051983954576_DN
DrugTremorine dihydrochloride [300-68-5]; Down 200; 15uM; MCF7; HT_HG-U133A

INCENP MAP3K6 ARHGEF1 USP20 MARK4

2.14e-051983953196_DN
DrugTelenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; HL60; HT_HG-U133A

MICALL1 DLX2 SLC15A3 SRGAP3 EPHA3

2.19e-051993952388_UP
DiseaseIntellectual Disability

KDM3B PRR12 SHANK2 KMT2E SRGAP3 ZMYM6

2.14e-05447386C3714756
DiseaseAbnormal behavior

KDM3B PRR12

1.92e-0416382C0233514
Diseaseimmature granulocyte count

PKN3 MARK4

2.17e-0417382EFO_0803542
DiseaseGlobal developmental delay

KDM3B PRR12 KMT2E

6.73e-04133383C0557874
Diseasevitamin D measurement

SHANK2 KMT2E LCE3D FAM110B

8.98e-04336384EFO_0004631
Diseaseautistic disorder (is_implicated_in)

SHANK2 KMT2E

1.35e-0342382DOID:12849 (is_implicated_in)
DiseaseAlzheimer disease

PMS2P1 ATXN7L1 WWC1 MARK4

3.42e-03485384MONDO_0004975
Diseasefamily history of Alzheimer’s disease

PMS2P1 MARK4

3.79e-0371382EFO_0009268
DiseaseAutistic Disorder

DLX2 SHANK2 KMT2E

4.59e-03261383C0004352
DiseaseHodgkins lymphoma

PRR12 SHANK2

5.03e-0382382EFO_0000183
DiseaseNeurodevelopmental Disorders

KMT2E SRGAP3

6.42e-0393382C1535926
Diseasephosphatidylinositol measurement

INCENP MBOAT7

6.69e-0395382EFO_0010230
DiseaseRetinitis Pigmentosa

UBAP1L ZNF408

7.96e-03104382C0035334
Diseasecalcium measurement

ATXN7L1 FAM178B PKN3 MARK4

8.46e-03628384EFO_0004838
DiseaseR-6-hydroxywarfarin measurement

SHANK2 ATXN7L1

9.50e-03114382EFO_0803327

Protein segments in the cluster

PeptideGeneStartEntry
APASRPKPRPSPSST

ARHGEF1

766

Q92888
AAPPCSPLLKAPSPA

CEBPE

176

Q15744
ASPPCASPPVSAPAS

DLX2

226

Q07687
CRPSPSPVSPASNPR

ATXN7L1

126

Q9ULK2
PPPPPKRSSSALASA

CASKIN1

946

Q8WXD9
LQPPRSKTPSSPCPA

INCENP

471

Q9NQS7
PRSSLSSPSPPCSPL

WWC1

536

Q8IX03
KAPRPPGQPPRASSC

LMAN1L

446

Q9HAT1
PPPCQSPASLSEPRK

C9orf131

341

Q5VYM1
PSQHPPSPPKRCLSY

MAP3K6

951

O95382
RPPSAALKPSACPEP

FBXO46

26

Q6PJ61
PSLPRSCGPKLTNSP

PFKFB3

21

Q16875
KAIRPPCPDTAPPSS

KDM3B

1206

Q7LBC6
CPPSPHLENPPKSST

KMT2E

1441

Q8IZD2
PTLQCPPPSSPEKAA

MBOAT7

276

Q96N66
SPPRKGLAPCSPPSV

MICALL1

116

Q8N3F8
PAELTPRSTPPHPCS

PMS2P1

406

A4D2B8
PTDPPSASCTRPPSA

EPHA10

326

Q5JZY3
RPPSPPKACSTPGSC

C4orf17

141

Q53FE4
DPPSMACTRPPSSPR

EPHA3

316

P29320
AARQCAPPPAPPTSS

HOXC13

101

P31276
CGPSPAPLHPKRSPT

MARK4

426

Q96L34
PLKAIPCSSSAPPLP

FAM110B

211

Q8TC76
CPPKSPVQCLPPASS

LCE3D

21

Q9BYE3
KRPSPPPSGAPCLNS

FOXI1

266

Q12951
PACPSAGCPRSSPSP

SLC15A3

141

Q8IY34
KQFSVPPAPTRPSCP

KIF2C

141

Q99661
SSPSLPPASPCPALA

MENT

296

Q9BUN1
SSPSTISPPKGCPRT

PKN3

466

Q6P5Z2
CSGSSPPRVKSSTPP

SRRM2

891

Q9UQ35
RPCSPASAPAPTSPK

FAM178B

81

Q8IXR5
PSRPVSTSASKPCLP

MRGPRG-AS1

81

Q2M3A8
PPPPRSTATPKCQSL

PRR12

406

Q9ULL5
PSPTTYNCPKSPTPR

SHANK2

901

Q9UPX8
PPRAAACPSSPHKIP

SRGAP3

886

O43295
KAPAPAPPPSGSTSC

SCAF1

661

Q9H7N4
SPSDQCPPRAKTPEP

ZNF408

311

Q9H9D4
PAEAQPPSPRSSSPC

USP20

361

Q9Y2K6
LCPSPAQSPRSASPP

UBAP1L

186

F5GYI3
ITRHSSPACLPPPPK

ZMYM6

121

O95789
PASPSCPSPVPQRRS

TBKBP1

386

A7MCY6